Atoxlab, Inc. was founded in 2017 with a vision to better the growth of young and dynamic Korean pharmaceutical and biotech industries. With more than 20 years of experience in biomedical sciences, we are rightly equipped in helping the industry finding cure for diseases and disorders.

In fact, we are very proud to see our clients succeeding in their drug development. Recent success stories by our clients in the application for IND (MFDS, FDA, and TGA) and clinical trials are the testament to our competency.

Our Services


Process Development, Method Development and Validation, Formulation, Stability, DS/DP Manufacturing

Nonclinical studies

In Vitro/In Vivo Models, ADME, PK, GLP Tox, DART, Carcinogenesis 

Clinical studies

Phase I, Phase IIa, PK Sample and Biomarker Analysis, Central Lab Services (CLIA)

Regulatory consulting

IND submission, CTD Writing (MFDS, TGA, US FDA, EMA)

Contact us


Make an appointment

CEO : John Yi
Phone : 82-10-7189-2962
Email : john.yi@atoxlab.co.kr

Come visit us

109, Pangyoyeok-ro, Bundang-gu, Seongnam-si,
 Gyeonggi-do, South Korea, 13531